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Cats are the only deﬁnitive hosts of Toxoplasma gondii and constitute an essential source of infection to all
warm blooded animals and humans. Diagnosis of T. gondii infection in cats is fundamental for proper
management and control of infection in humans and animals. In the current study, we have evaluated the
diagnostic performance of tachyzoite lysate antigen (TLA) and different T. gondii recombinant antigens
including surface antigen 2 (SAG2), dense granule proteins 2, 6, 7, 15 (GRA2, GRA6, GRA7, GRA15) and
microneme 10 protein (MIC10) in immunoglobulin G enzyme linked-immunosorbent assay (IgG ELISA)
using cat serum samples, with reference to latex agglutination test (LAT). Remarkably, TLA showed better
performance than other recombinant antigens in IgG ELISAs as compared to LAT, with concordance and
Kappa values of 94.27% and 0.93, respectively. Furthermore, to improve the reactivity of the recombinant
antigens, we have developed IgG ELISAs using different combinations with these recombinant antigens.
Strikingly, a combination of SAG2 and GRAs has relatively similar performance as TLA evidenced by
concordance and Kappa values of 94.27% and 0.81, respectively. The developed ELISA with a combination
of recombinant antigens can be used as a promising diagnostic tool for routine testing of T. gondii
infection and mass screening in cats. The major advantages of this assay are the high sensitivity and
speciﬁcity, lower cost, safer production and easiness of standardization in various laboratories worldwide.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).).
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Primers used for cloning of T. gondii genes.
Genes Primer sequence Enzyme site
sag2 50-ttttggatcctccaccaccgagacgcca-30 BamH1
50-ttttgaattcttacttgcccgtgagaga-30 EcoR1
gra2 50-ttggatccatgttcgccgtaaaacat-30 BamH1
50-ttctcgagttactgcgaaaagtctgg-30 Xho1
gra6 50-ttttggatccatggcacacggtggcatccatctga-30 BamH1
50-ttttgaattcataatcaaacacattcacacgttcc-30 EcoR1
gra7 50-ttttggatccgatgacgaactgatgagt-30 BamH1
50-ttttgaattcctactggcgggcatcctccccatctt-30 EcoR1
gra15 50-ttttggatccatggtgacaacaaccacgccaacgc-30 BamH1
50-ttttctcgagtggagttaccgctgattgtgtgtcc-30 Xho1
mic10 50-ttggatccagtctccaggcgtctattgg-30 BamH1
50-ttctcgagctacattgatttcctgcgtc-30 Xho1
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Toxoplasmosis is globally prevalent zoonotic disease caused by
the intracellular protozoan parasite Toxoplasma gondii (T. gondii)
(Tenter et al., 2000). Prevalence of infection is often highest in re-
gions of the world that have hot, humid climates and lower alti-
tudes. Felids are the deﬁnitive hosts of this parasite and mostly all
warm-blooded mammals including humans serve as intermediate
hosts (Dabritz and Conrad, 2010; Elmore et al., 2010). Transmission
to humans and animals occurs via ingestion of food and water
contaminated with infectious oocysts shed in cat feces (Dubey and
Beattie, 1988). Postnatal infection causes fatal encephalitis in
immunocompromised patients such as those with AIDS. Congenital
infection may cause abortion, neonatal deaths, or foetal abnor-
malities result in blindness and mental retardation in pregnant
woman (Jones et al., 2003; Luft et al., 1984). In animals, it causes
abortion and stillbirth in all types of livestock, especially in sheep
and goats resulting in signiﬁcant reproductive and economic losses
(Buxton, 1998).
Little attention has been paid to feline toxoplasmosis, because
T. gondii infection in cats is usually asymptomatic and latent in-
fections are the most common. Development of accurate diagnostic
tests in cats is crucial for proper management and control of
T. gondii infection. Several assays have been developed for diagnosis
of T. gondii infection in humans and animals. Serological techniques
seem to be the most suitable for routine mass screening of samples
(Montoya, 2002). TLA has been traditionally used in serological
detection of T. gondii infection, however, the recombinant proteins
offer better test standardization with less production costs.
Although number of immunodominant antigens has been used for
serodiagnosis of feline toxoplasmosis (Cai et al., 2015;
Hosseininejad, 2012; Huang et al., 2002; Kimbita et al., 2001),
none of these showed all criteria required to replace the native
antigen of T. gondii in serological tests. Therefore, further research is
required to develop an accurate serodiagnostic test in cats. In the
present study, we have evaluated the diagnostic performance of
recombinant protein antigens and different combinations for the
serodiagnosis of feline toxoplasmosis. Our results indicate that a
combination of SAG2, GRA2, GRA6, GRA7, and GRA15 can be used as
a promising tool for detection of T. gondii infection in cats using
ELISA. This is the ﬁrst report demonstrating the usefulness of
combination formula antigen in diagnosis of feline toxoplasmosis.
2. Materials and methods
2.1. Preparation of T. gondii lysate antigen (TLA)
Tachyzoites were maintained in human foreskin ﬁbroblast (HFF)
cells cultured in Dulbecco's Modiﬁed Eagle's Medium (DMEM,
GIBCO, Grand Island, NE, U.S.A.) supplemented with 7.5% heat-
inactivated fetal bovine serum (FBS). TLA preparation was based
on the standard procedure, by three times freezing and thawing of
tachyzoites obtained from T. gondii (ME49 strains).
2.2. Cloning of T. gondii genes
The cloning of T. gondii genes encoding SAG2 (from position 79
to 516 bp), GRA2 (from position 1 to 558 bp), GRA6 (from position 1
to 690 bp), GRA7 (from position 91 to 711 bp), GRA15 (from position
1 to 1650 bp), MIC10 (from Position 148 to 597 bp) proteins was
conducted. The RNA was extracted from the puriﬁed tachyzoites
(RH strain) using a commercial RNeasy mini kit (QIAGEN) and
reverse transcribed using One step RNA PCR kit for reverse tran-
scription (One step RNA PCR kit, Takara, Japan) and then used as a
template to amplify the target genes. Oligonucleotide primers usedfor ampliﬁcation of T. gondii genes were shown in Table 1. The
ampliﬁed cDNAs of SAG2, GRA6, and GRA7 were double digested
with BamHI and EcoRI whereas that of GRA2, GRA15 andMIC10were
double digested with BamHI and XhoI, and subcloned into the
identical restriction sites of pGEX-5X-1 or pGEX-6P2 (GE Health-
care UK Ltd.). Plasmids were transformed into Escherichia coli DH5a
competent cells. Cycle sequencing reactions were carried out using
a BigDye Terminator Cycle Sequencing kit Ver. 3.1 according to the
manufacturer's protocol (Applied Biosystems, USA), and each
sample was analyzed using an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, USA).
2.3. Expression and puriﬁcation of recombinant fusion proteins
The resulting plasmids were transfected in E. coli strain BL21
(DE3) pLysS cells. Then, the GST-fused proteins were induced with
isopropyl-b-D-thiogalactopyranoside (IPTG) to a ﬁnal concentra-
tion of 1 mM with mild shaking at 23 C overnight. The cells were
centrifuged at 5000g for 20 min and the bacterial pellet was
resuspended with 20 ml pre-chilled STE buffer (150 mM NaCl,
50 mM Tris-HCl [pH 9.5] and 1 mM EDTA [pH 8.0]), then stored
at 20 C. After thawing, the cells were disrupted by sonication on
ice for 10 min, and 20% (w/v) Triton X-100 in 1  PBS was added to
the samples to be a ﬁnal concentration of 1% (w/v) Triton X-100.
Total proteins in the soluble fraction were afﬁnity puriﬁed by
glutathione-Sepharose beads according to the manufacturer's
protocols (Pharmacia biotech, Uppsala, Sweden). The eluted frac-
tions were dialysed against PBS and the amount of recombinant
protein was measured using both SDS-PAGE and the Coomassie
protein assay reagent kit using BSA as a calibration standard ac-
cording to the manufacturer's protocol (Pierce Biotechnology, Inc.,
USA). All recombinant proteins remained soluble during puriﬁca-
tion and conservation. Apparent recombinant antigens on SDS-
PAGE match the expected size of each protein (data not shown).
2.4. Cat serum samples
A total of 419 serum samples were obtained from cats visiting
animal hospitals in Tokachi prefecture. The serum samples were
then prepared and stored at 30 C for future use.
2.5. IgG ELISA
MaxiSorp plates (Nunc, Denmark) were coated overnight at 4 C
with either single recombinant antigen, mixture of recombinant
proteins, or TLA at a ﬁnal concentration of 1 mg/ml of each antigen
in a coating buffer (50 mM carbonate, pH 9.6) and were incubated.
Plates were washed and blocked with 3% skim milk in phosphate
buffer saline (PBS-SM) for 1 h at room temperature (RT). 50 ml cat
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incubated for 1 h at RT. After washing, the plates were incubated
with horseradish peroxidase (HRP)-conjugated goat anti-cat IgG
(GE Healthcare UK Limited, Buckinghamshire, U.K.) diluted at
1:4000 with PBS-SM at RT for 1 h. Thereafter, plates were washed 6
times before the 100 ml substrate solution [0.1M citrate buffer, pH 4,
0.003% H2O2 and 0.3 mg/ml 2, 20-Azino-bis (3-
ethylbenzothiazoline-6-sulfonic acid); Sigma-Aldrich] was added
to each well. The absorbance was measured at 415 nm after 30 min
of incubation at RT using an ELISA reader (Coronamicroplate reader
MTP-120; Corona, Tokyo, Japan). Each serum sample was examined
twice. The results were determined for each sample by calculating
the mean optical density (OD) reading of duplicate wells. The cutoff
value of each single recombinant antigen, mixture of recombinant
proteins, or TLA antigen was calculated as the average OD plus 3
standard deviations of 10 cat serum samples, seronegative by LAT,
western blot and immunoﬂuorescence tests.
2.6. Latex agglutination test (LAT)
The LAT was performed according to the kit manufacturer's
instructions (Toxocheck-MT, Eiken Chemical, Tokyo, Japan). Sam-
ples were considered positive when agglutination was observed at
a dilution of 1:32 or greater.
2.7. Statistical analysis
The results of LAT and ELISA were estimated by the percentage
of agreement, the sensitivity and speciﬁcity, and the kappa values
with 95% conﬁdence interval (http://vassarstats.net/). The strength
of agreement was graded with kappa values of fair (0.21e0.40),
moderate (0.41e0.60), substantial (0.61e0.80), and perfect
(0.81e1.0).
3. Results
Cat serum samples were tested primarily by LAT as a reference
test. Out of 419 cat samples, 73 were positive and 346 were nega-
tive. The sensitivity, speciﬁcity, concordance and kappa values ob-
tainedwith the use of different recombinant antigens and TLAwere
variable (Table 2). Among these antigens, TLA yielded a perfect
concordance with LAT results, as evidenced by kappa values of
(0.93) with a high sensitivity and speciﬁcity 97.29% and 93.62%,
respectively. Recombinant SAG2 and GRA6 proteins showed greater
performance than other recombinant proteins with substantial
kappa values of 0.67 and 0.62, respectively. On the other hand,
recombinant GRA2 and GRA7, GRA15 and MIC10 proteins exhibited
lesser performance in detection of T. gondii antibodies. TheseTable 2
Performance evaluation of IgG-ELISA with TLA and recombinant proteins as
compared to LAT.
Antigen Sensitivity (%) Speciﬁcity (%) Concordance (%) Kappa value
SAG2 91.89 88.12 88.78 0.67
GRA2 27.03 96.52 84.25 0.30
GRA6 82.43 88.69 87.59 0.62
GRA7 35.1 89.86 80.19 0.27
GRA15 17.57 86.38 74.22 0.04
MIC10 16.21 85.8 73.51 0.02
TLA 97.29 93.62 94.27 0.93
M1 74.32 88.99 86.4 0.58
M2 44.59 89.28 81.38 0.35
M3 90.54 85.51 86.4 0.62
M4 94.59 89.57 90.45 0.72
M5 70.27 86.09 83.29 0.50
M6 89.19 95.36 94.27 0.81results indicate that TLA has a better performance than single re-
combinant proteins in diagnosing feline toxoplasmosis.
To further improve the diagnostic performance of IgG ELISA,
different combination formula of recombinant proteins (M1:
GRA6 þ GRA7; M2: GRA2 þ GRA7; M3: SAG2 þ GRA7; M4:
SAG2 þ GRA6; M5: GRA2 þ GRA6 þ GRA7 þ GRA15; M6:
SAG2þ GRA2þ GRA6þGRA7þGRA15) was used as ELISA antigen.
Results were compared to these of LAT to assess their speciﬁcity
and sensitivity. The M1 and M5 had a moderate concordance as
evidenced by kappa values of 0.58 and 0.5, respectively. Fair
concordance was yielded by M2 with kappa value of 0.35. Sub-
stantial concordance was yielded by M4 and M3 with kappa values
of 0.72 and 0.62, respectively. Noteworthy, M6 exhibited the
highest concordance, as evidenced by kappa value of 0.81, sensi-
tivity, 89.19% and speciﬁcity 95.36% (Table 2). Indeed, the reactivity
of IgG ELISA for M6was relatively similar to TLA-ELISA as compared
to the results of LAT (Fig. 1). Collectively, IgG ELISA based on com-
bination formula of recombinant antigens has more potent diag-
nostic performance than this based on single recombinant antigen
for detection of T. gondii infection in cats.
4. Discussion
Development of an accurate diagnostic method to detect
T. gondii in cats is required to minimize the risk of transmission to
humans and animals. Although LAToffers the advantage that can be
used in serum samples from various species including felines, it
does not provide information on the stage of infection as it did not
detect adequately T. gondii-speciﬁc IgM in feline serum (Lappin and
Powell, 1991). Recently, it was reported a LAT based on an acute
phase recombinant protein in order to discriminate acute from
chronic infection in humans, although it could also be applied in
cats (Peretti et al., 2016). Bacterial recombinant antigens offer many
advantages in the diagnosis as they allow better standardization of
the tests and reduce the costs of production and puriﬁcation
(Pietkiewicz et al., 2004). However, many recombinant proteins
have shown poor antigenicity and reactivity with ﬁeld samples
when they tested as ELISA antigen. Alternative approach is the use
of antigens combination formula representative of the whole
complex of T. gondii antigens.
A limited number of studies evaluated IgG ELISA assays based on
recombinant antigens to diagnose feline toxoplasmosis in single
but not in combination formula (Cai et al., 2015; Hosseininejad,
2012; Huang et al., 2002; Kimbita et al., 2001). On the other
hand, several recombinant combinations were employed for the
detection of T. gondii using IgG ELISA in human sera. For instance,
the combination of recombinant GRA7with ROP2 has increased the
sensitivity to 96% (Jacobs et al., 1999), while combination of GRA7,
GRA8, and SAG1 resulted in an improved sensitivity and speciﬁcity
of the assay (Aubert et al., 2000). Likewise, GRA1 and GRA6 showed
98% sensitivity (Lecordier et al., 2000), and combined GRA7, GRA8,
SAG2, and H4 has a sensitivity and speciﬁcity of 90% and 97%,
respectively (Li et al., 2000). Combination of SAG1, GRA1, and GRA7
resulted in 100% sensitivity (Pietkiewicz et al., 2004). Moreover,
combined GRA8, GRA6 with SAG2 has exhibited 94.4% sensitivity
(Holec et al., 2008). Combination of SAG1 and GRA5 mixed with
MAG1 or GRA2 or ROP1 increased sensitivity to 92.6%, 93.1% and
94.2%, respectively (Holec-Ga˛sior and Kur, 2010).
In the present study, the diagnostic utility of IgG ELISAs
employing TLA, six recombinant antigens and six cocktail formula
was evaluated in cat sera for detection of T. gondii infection. The IgG
ELISAs with single recombinant protein formula showed weaker
performance than that with TLA. Recombinant SAG2 protein has a
greater performance than other recombinant proteins. This ﬁnding
was consistent with previous investigators (Huang et al., 2002) who
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Fig. 1. Comparison between titers of sera by LAT with distribution of ELISA-ODs based on TLA (A) and recombinant combination formula M6 (B). Each circle indicates average OD of
ELISA.
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toxoplasmosis. Different levels of sensitivity and speciﬁcity of re-
combinant GRA7 between our results and those of previous study
(Cai et al., 2015) could be attributed to variations in cloning stra-
tegies and recombinant protein puriﬁcationmethods (Kotresha and
Noordin, 2010; Holec-Ga˛sior, 2013). Interestingly, combination
formula composed of SAG2, GRA2 þ GRA6 þ GRA7 þ GRA15
exhibited relatively similar performance as TLA ELISA. Our results
seemed to be consistent with previous studies noted that combi-
nation antigen formula improves the diagnostic performance of an
immunoassay. The greater diagnostic performance of combination
antigen formula may be due to recognition of multiple different
epitopes of various antigens by speciﬁc antibodies present in the
serum from acute and/or chronic T. gondii infection.
In conclusion, our results suggest a high diagnostic usefulness of
IgG ELISA based on a combination formula of SAG2,
GRA2þ GRA6þ GRA7 þ GRA15 for detection of T. gondii antibodies
in cats sera. The current ELISA with M6 offers a promising tool for
accurate serodiagnosis of toxoplasmosis in cats.
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